Zantac 150 (Ranitidine Hydrochloride)


Indications and Reactions:

Role Indications Reactions
Primary
Dyspepsia 56.2%
Gastrooesophageal Reflux Disease 9.4%
Hypertension 4.9%
Anxiety 2.9%
Asthma 2.9%
Ulcer 2.9%
Gastric Ulcer 1.9%
Nausea 1.9%
Product Used For Unknown Indication 1.9%
Blood Cholesterol Increased 1.6%
Cardiac Disorder 1.6%
Flatulence 1.6%
Hypothyroidism 1.6%
Supplementation Therapy 1.6%
Abdominal Pain Upper 1.3%
Diabetes Mellitus 1.3%
Prostatomegaly 1.3%
Abdominal Discomfort 1.0%
Barrett's Oesophagus 1.0%
Bipolar Disorder 1.0%
Off Label Use 30.4%
Dyspepsia 15.8%
Drug Ineffective 13.3%
Product Quality Issue 7.0%
Intentional Drug Misuse 4.4%
Drug Interaction 2.5%
Faeces Discoloured 2.5%
Overdose 2.5%
Abdominal Pain Upper 1.9%
Accidental Exposure To Product By Child 1.9%
Drug Effect Decreased 1.9%
Drug Screen Positive 1.9%
Eructation 1.9%
Headache 1.9%
Hyperchlorhydria 1.9%
Nausea 1.9%
Viral Infection 1.9%
Vomiting 1.9%
Adverse Drug Reaction 1.3%
Flatulence 1.3%
Secondary
Dyspepsia 47.4%
Hypertension 6.6%
Cardiac Disorder 4.8%
Gastrooesophageal Reflux Disease 4.8%
Gastric Ulcer 3.9%
Flatulence 3.5%
Atrial Fibrillation 2.6%
Blood Cholesterol Increased 2.6%
Supplementation Therapy 2.6%
Abdominal Distension 2.2%
Antiallergic Therapy 2.2%
Anxiety 2.2%
Asthma 2.2%
Gastric Ph Decreased 2.2%
Histamine Level Increased 2.2%
Muscle Spasms 2.2%
Chronic Obstructive Pulmonary Disease 1.8%
Blood Pressure 1.3%
Depression 1.3%
Diabetes Mellitus 1.3%
Off Label Use 28.8%
Dyspepsia 11.9%
Product Quality Issue 8.5%
Drug Ineffective 6.8%
Viral Infection 6.8%
Incorrect Drug Administration Duration 5.1%
Intentional Drug Misuse 5.1%
Faeces Discoloured 3.4%
Throat Irritation 3.4%
Vomiting 3.4%
Chest Discomfort 1.7%
Chromaturia 1.7%
Drug Effect Decreased 1.7%
Dysgeusia 1.7%
Dyspnoea 1.7%
Feeling Abnormal 1.7%
Flatulence 1.7%
Gastrooesophageal Reflux Disease 1.7%
Haematuria 1.7%
Headache 1.7%

Drug Data